Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination K Natarajan, N Dimasi, J Wang, RA Mariuzza, DH Margulies Annual review of immunology 20 (1), 853-885, 2002 | 451 | 2002 |
A biparatopic HER2-targeting antibody-drug conjugate induces tumor regression in primary models refractory to or ineligible for HER2-targeted therapy JY Li, SR Perry, V Muniz-Medina, X Wang, LK Wetzel, MC Rebelatto, ... Cancer cell 29 (1), 117-129, 2016 | 352 | 2016 |
A multifunctional bispecific antibody protects against Pseudomonas aeruginosa A DiGiandomenico, AE Keller, C Gao, GJ Rainey, P Warrener, ... Science translational medicine 6 (262), 262ra155-262ra155, 2014 | 278 | 2014 |
Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2Kb J Dam, R Guan, K Natarajan, N Dimasi, LK Chlewicki, DM Kranz, ... Nature immunology 4 (12), 1213-1222, 2003 | 164 | 2003 |
Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II Y Li, H Li, N Dimasi, JK McCormick, R Martin, P Schuck, PM Schlievert, ... Immunity 14 (1), 93-104, 2001 | 159 | 2001 |
Human natural killer cell receptors: insights into their molecular function and structure R Biassoni, C Cantoni, D Marras, J Giron‐Michel, M Falco, L Moretta, ... Journal of cellular and molecular medicine 7 (4), 376-387, 2003 | 155 | 2003 |
Multispecific epitope binding proteins and uses thereof H Wu, C Gao, C Hay, N Dimasi | 141 | 2013 |
Affinity selection of a camelized V (H) domain antibody inhibitor of hepatitis C virus NS3 protease. F Martin, C Volpari, C Steinkuhler, N Dimasi, M Brunetti, G Biasiol, ... Protein Engineering 10 (5), 607-614, 1997 | 140 | 1997 |
Binding specificity of multiprotein signaling complexes is determined by both cooperative interactions and affinity preferences JCD Houtman, Y Higashimoto, N Dimasi, S Cho, H Yamaguchi, ... Biochemistry 43 (14), 4170-4178, 2004 | 130 | 2004 |
Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides RJ Christie, R Fleming, B Bezabeh, R Woods, S Mao, J Harper, A Joseph, ... Journal of controlled release 220, 660-670, 2015 | 128 | 2015 |
The design and characterization of oligospecific antibodies for simultaneous targeting of multiple disease mediators N Dimasi, C Gao, R Fleming, RM Woods, XT Yao, L Shirinian, PA Kiener, ... Journal of molecular biology 393 (3), 672-692, 2009 | 118 | 2009 |
Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin L Musante, G Candiano, A Petretto, M Bruschi, N Dimasi, G Caridi, ... Journal of the American Society of Nephrology 18 (3), 799-810, 2007 | 103 | 2007 |
Structural and functional aspects of the Ly49 natural killer cell receptors N Dimasi, R Biassoni Immunology and cell biology 83 (1), 1-8, 2005 | 94 | 2005 |
Structural basis of MHC class I recognition by natural killer cell receptors MW Sawicki, N Dimasi, K Natarajan, J Wang, DH Margulies, RA Mariuzza Immunological reviews 181 (1), 52-65, 2001 | 93 | 2001 |
Characterization of oxidation end product of plasma albumin ‘in vivo’ L Musante, M Bruschi, G Candiano, A Petretto, N Dimasi, P Del Boccio, ... Biochemical and biophysical research communications 349 (2), 668-673, 2006 | 89 | 2006 |
Antibody–drug conjugates bearing pyrrolobenzodiazepine or tubulysin payloads are immunomodulatory and synergize with multiple immunotherapies J Rios-Doria, J Harper, R Rothstein, L Wetzel, J Chesebrough, A Marrero, ... Cancer research 77 (10), 2686-2698, 2017 | 86 | 2017 |
Efficient preparation of site-specific antibody–drug conjugates using cysteine insertion N Dimasi, R Fleming, H Zhong, B Bezabeh, K Kinneer, RJ Christie, ... Molecular pharmaceutics 14 (5), 1501-1516, 2017 | 78 | 2017 |
Characterization of engineered hepatitis C virus NS3 protease inhibitors affinity selected from human pancreatic secretory trypsin inhibitor and minibody repertoires N Dimasi, F Martin, C Volpari, M Brunetti, G Biasiol, S Altamura, R Cortese, ... Journal of Virology 71 (10), 7461-7469, 1997 | 75 | 1997 |
Expression, crystallization and X-ray data collection from microcrystals of the extracellular domain of the human inhibitory receptor expressed on myeloid cells IREM-1 N Dimasi, D Flot, F Dupeux, JA Márquez Acta Crystallographica Section F: Structural Biology and Crystallization …, 2007 | 69 | 2007 |
SLC46A3 as a potential predictive biomarker for antibody–drug conjugates bearing noncleavable linked maytansinoid and pyrrolobenzodiazepine warheads K Kinneer, J Meekin, AC Tiberghien, YT Tai, S Phipps, CM Kiefer, ... Clinical Cancer Research 24 (24), 6570-6582, 2018 | 65 | 2018 |